Yitong Zhang

Dr. Yitong Zhang

Department of Biochemistry and Molecular Biology,Harbin Medical University
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2020 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
DWDaming Wang
Daming Wang
SHShaogui He
Shaogui He
XWXiaohui Wang
Xiaohui Wang
YYYouqin Yan
Youqin Yan
JLJianzhong Liu
Jianzhong Liu
YTYuguo Tang
Yuguo Tang

27 February 2020 in Genes
Verified
Journal Article
Open access
PDF file
Yitong ZhangYitong Zhang
Yitong Zhang
JTJoseph Ta-Chien Tseng
Joseph Ta-Chien Tseng
ILI-Chia Lien
I-Chia Lien
FLFenglan Li
Fenglan Li
WWWei Wu
Wei Wu
HLHui Li
Hui Li
Cancer stem cells (CSCs), characterized by self-renewal and unlimited proliferation, lead to therapeutic resistance in lung cancer. In this study, we aimed to investigate the expressions of stem cell-related genes in lung adenocarcinoma (LUAD). The stemness index based on mRNA expression (mRNAsi) was utilized to analyze LUAD cases in the Cancer Genome Atlas (TCGA). First, mRNAsi was analyzed with differential expressions, survival analysis, clinical stages, and gender in LUADs. Then, the weighted gene co-expression network analysis was performed to discover modules of stemness and key genes. The interplay among the key genes was explored at the transcription and protein levels. The enrichment analysis was performed to annotate the function and pathways of the key genes. The expression levels of key genes were validated in a pan-cancer scale. The pathological stage associated gene expression level and survival probability were also validated. The Gene Expression Omnibus (GEO) database was additionally used for validation. The mRNAsi was significantly upregulated in cancer cases. In general, the mRNAsi score increases according to clinical stages and differs in gender significantly. Lower mRNAsi groups had a better overall survival in major LUADs, within five years. The distinguished modules and key genes were selected according to the correlations to the mRNAsi. Thirteen key genes (CCNB1, BUB1, BUB1B, CDC20, PLK1, TTK, CDC45, ESPL1, CCNA2, MCM6, ORC1, MCM2, and CHEK1) were enriched from the cell cycle Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, relating to cell proliferation Gene Ontology (GO) terms, as well. Eight of the thirteen genes have been reported to be associated with the CSC characteristics. However, all of them have been previously ignored in LUADs. Their expression increased according to the pathological stages of LUAD, and these genes were clearly upregulated in pan-cancers. In the GEO database, only the tumor necrosis factor receptor associated factor-interacting protein (TRAIP) from the blue module was matched with the stemness microarray data. These key genes were found to have strong correlations as a whole, and could be used as therapeutic targets in the treatment of LUAD, by inhibiting the stemness features.

21 September 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
Yitong ZhangYitong Zhang
Yitong Zhang
FLFenglan Li
Fenglan Li
KFKexin Fu
Kexin Fu
XLXiqing Liu
Xiqing Liu
ILI-Chia Lien
I-Chia Lien
HLHui Li
Hui Li
S-palmitoylation, catalyzed by a family of 23 zinc finger Asp-His-His-Cys (DHHC) domain-containing (ZDHHC) protein acyltransferases localized on the cell membrane. However, stemness genes modulated by ZDHHCs in lung adenocarcinoma (LUAD) remain to be defined. Previously, we have constructed a network of cancer stem cell genes, including INCENP, based on mRNA stemness indices (mRNAsi) of LUAD. INCENP has the function of a chromosomal passenger complex locating to centromeres, which is performed by the conserved region of its N-terminal domain. INCENP protein with a deletion of the first non-conserved 26 amino acid sequence failed to target centromeres. However, the exact function of the deleted sequence has not been elucidated. To identify novel cancer stem cell-relevant palmitoylated proteins and responsible ZDHHC enzymes in LUAD, we analyzed multi-omics data obtained from the database of The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), Clinical Proteomic Tumor Analysis Consortium (CPTAC), and the Human Protein Atlas (HPA). ZDHHC5 is distinguished from the ZDHHC family for being up-regulated in mRNA and protein levels and associated with malignant prognosis. ZDHHC5 was positively associated with INCENP, and the correlation score increased with LUAD stages. CSS-Palm results showed Cys15 was the S-palmitoylation site of INCENP. Interestingly, Cys15 locates in the 1–26 aa sequence of INCENP, and is a conserved site across species. As INCENP is a nuclear protein, we predicted that the nuclear localization signal of ZDHHC5 was specific to the importin αβ pathway, and the result of immunofluorescence proves that ZDHHC5 is located in the nucleoplasm, in addition to the plasma membrane. Therefore, our study indicates the S-palmitoylation of INCENP mediated by ZDHHC5 as a potential mechanism of S-palmitoylation to modulate CSCs in LUAD.

14 March 2020 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
HLHehuan Lai
Hehuan Lai
TNTingting Nie
Tingting Nie
Yitong ZhangYitong Zhang
Yitong Zhang
YCYing Chen
Ying Chen
JTJiaqi Tao
Jiaqi Tao
HLHui Li
Hui Li

12 September 2016 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
RLRuxian Li
Ruxian Li
YLYushuang Liu
Yushuang Liu
NCNan Chen
Nan Chen
Yitong ZhangYitong Zhang
Yitong Zhang
GSGe Song
Ge Song
ZZZhongling Zhang
Zhongling Zhang
BACKGROUND:Migraine is a chronic disease that interferes with life quality and work productivity. Valproate shows protective effects against migraine, yet the underlying mechanisms are unclear. This study aimed to evaluate the potential effect of val...

1 December 2021 in Gene
Verified
Journal Article
Closed access
Yitong ZhangYitong Zhang
Yitong Zhang
DLDongzhe Liu
Dongzhe Liu
FLFenglan Li
Fenglan Li
ZZZihui Zhao
Zihui Zhao
XLXiqing Liu
Xiqing Liu
HLHui Li
Hui Li